Details for New Drug Application (NDA): 021114

✉ Email this page to a colleague

NDA 021114 describes BETAXON, which is a drug marketed by Alcon Pharms Ltd and is included in one NDA. Additional details are available on the BETAXON profile page.

The generic ingredient in BETAXON is levobetaxolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levobetaxolol hydrochloride profile page.

Summary for 021114

Tradename:	BETAXON
Applicant:	Alcon Pharms Ltd
Ingredient:	levobetaxolol hydrochloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SUSPENSION/DROPS;OPHTHALMIC			Strength	EQ 0.5% BASE
Approval Date:	Feb 23, 2000	TE:		RLD:	No

Expired US Patents for NDA 021114

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	4,911,920*PED	⤷ Subscribe
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	5,540,918*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.